BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21105798)

  • 1. The role of allogeneic-cell transplantation in leukemia.
    Kersey JH
    N Engl J Med; 2010 Nov; 363(22):2158-9. PubMed ID: 21105798
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
    de Lima M; Giralt S
    Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin.
    Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extramedullary relapse of therapy-related myelodysplastic syndrome after donor leukocyte infusion.
    Chao MM; Kontny U; Brink I; Göhring G; Schmitt-Gräff A; Rister M; Strahm B
    Ann Hematol; 2008 Feb; 87(2):165-6. PubMed ID: 17805535
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
    Chaidos A; Kanfer E; Apperley JF
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long-term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON).
    Muñoz A; Badell I; Olivé T; Verdeguer A; Gómez P; Bureo E;
    Haematologica; 2002 Mar; 87(3):331-2. PubMed ID: 11869952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients.
    Sun JY; Dagis A; Gaidulis L; Miller MM; Rodriguez R; Parker P; Nademanee A; Falk P; Rosenthal J; Forman SJ; Senitzer D
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):197-205. PubMed ID: 17241925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease.
    Davies JK; Taussig DC; Oakervee H; Davies AJ; Agrawal SG; Gribben JG; Lister TA; Cavenagh JD
    J Clin Oncol; 2006 May; 24(14):e23-5. PubMed ID: 16682729
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic hematopoietic stem cell transplantation for acute leukemia, chronic leukemia, and myelodysplasia.
    Popplewell L; Forman SJ
    Hematol Oncol Clin North Am; 1999 Oct; 13(5):987-1015, vi-vii. PubMed ID: 10553258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic and autologous stem cell transplantation in myelodysplastic syndromes.
    De Witte T
    Pathol Biol (Paris); 1997 Oct; 45(8):643-9. PubMed ID: 9569930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinus bradycardia associated with cyclosporine following allogeneic hematopoietic stem cell transplantation.
    Fujisaki G; Kami M; Murashige N; Kishi Y; Inokuchi C; Tanosaki R; Momomura S
    Bone Marrow Transplant; 2005 Jan; 35(2):211-2. PubMed ID: 15531900
    [No Abstract]   [Full Text] [Related]  

  • 14. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
    Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno NT; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson BS; Estey EH; Champlin R; Przepiorka D
    Am J Hematol; 2001 Aug; 67(4):227-33. PubMed ID: 11443634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hematopoietic stem cell transplantation in acute myelogenous leukemia and myelodysplastic syndrome.
    Tallman MS; Mathews V; DiPersio JF
    Cancer Treat Res; 2009; 144():415-39. PubMed ID: 19779880
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
    Laughlin MJ; Eapen M; Rubinstein P; Wagner JE; Zhang MJ; Champlin RE; Stevens C; Barker JN; Gale RP; Lazarus HM; Marks DI; van Rood JJ; Scaradavou A; Horowitz MM
    N Engl J Med; 2004 Nov; 351(22):2265-75. PubMed ID: 15564543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.
    Ringdén O
    Stem Cells Dev; 2009 Nov; 18(9):1243-6. PubMed ID: 19905962
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes.
    de Witte T; Brand R; van Biezen A; Delforge M; Biersack H; Or R; Meloni G; Bandini B; Sierra J; Kroger N; Gratwohl A; Niederwieser D;
    Haematologica; 2006 Jun; 91(6):750-6. PubMed ID: 16769576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
    Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
    Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
    Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
    Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.